Ghost Tree Capital, LLC Immunovant, Inc. Call Options Transaction History

Ghost Tree Capital, LLC

  • $267 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$30.27 - $43.79 $4.54 Million - $6.57 Million
150,000 New
150,000 $4.85 Million
Q4 2021

Feb 16, 2022
SELL
$7.33 - $9.32 $1.47 Million - $1.86 Million
-200,000 Closed
0 $0
Q2 2021

Aug 11, 2021
BUY
$9.4 - $16.85 $1.88 Million - $3.37 Million
200,000 New
200,000 $2.11 Million

Others Institutions Holding IMVT

# of Institutions
212
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email